Sickle cell disease trials in Ghana
1 of 4 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleVerifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease
- Where
- Accra
- Age
- 6 months to 6 years
- People
- 130 worldwide
- Run by
- Children's Hospital Medical Center, Cincinnati
See details and how to joinNCT07356050